Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Psychogenic movement disorders (PMDs) manifest with physical symptoms but currently lack a clear pathology and standard of care. However, some physicians support the use of placebo therapy for patients with PMDs. In this Perspectives article, Karen Rommelfanger outlines the need for further research and international dialog regarding the treatment of patients with PMDs, and the use of placebo therapy in these patients.
